The other 20% of infant ALL cases that were not KMT2A-rearranged, also known as KMT2A-germline since the gene remained in its unaltered (germline) configuration, were found to carry somatic rearrangements in other oncogenes. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.